Healthcare utilisation and measles, mumps and rubella vaccination rates among children with an extended postnatal home visiting programme in a disadvantaged area in Stockholm, Sweden-A 3-year follow-up

Acta Paediatr. 2020 Sep;109(9):1847-1853. doi: 10.1111/apa.15176. Epub 2020 Feb 3.

Abstract

Aim: To follow up healthcare utilisation and measles, mumps and rubella (MMR) vaccination rates among children 0-36 months, receiving an extended postnatal home visiting programme in a disadvantaged area with poorer child health, and in control groups, in Stockholm, Sweden.

Methods: We analysed electronic child health records regarding outpatient visits, inpatient episodes and MMR vaccination for children 0-36 months receiving the home visiting programme (Intervention Group) and in control groups (Control Group and Rinkeby Comparison Group).

Results: Children in the Intervention Group had significantly higher MMR vaccination rate than children in the Rinkeby Comparison Group. Healthcare utilisation was similar in the Intervention Group and the control groups. In stratified analyses by number of home visits received, children receiving the recommended six home visits had significantly fewer inpatient episodes and somewhat fewer emergency visits than those receiving fewer home visits.

Conclusion: The extended home visiting programme had a positive impact on the MMR vaccination rate. Children receiving the recommended six home visits had lower use of inpatient care. In addition to being positively perceived by parents in an area with greater healthcare needs, the programme may have a positive impact on their children's healthcare utilisation.

Keywords: health care; home visit; vaccination rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • Child
  • Follow-Up Studies
  • Humans
  • Infant
  • Measles* / prevention & control
  • Measles-Mumps-Rubella Vaccine
  • Mumps* / prevention & control
  • Rubella* / prevention & control
  • Sweden
  • Vaccination
  • Vulnerable Populations

Substances

  • Antibodies, Viral
  • Measles-Mumps-Rubella Vaccine